Longevity & AgingGLP-1 Use Hits Record Highs as New Data Reshapes Metabolic Health Strategies
GLP-1 drug use in the US has nearly quadrupled since 2024, according to a new Gallup poll, while fresh clinical data shows these medications reduce mortality and complications in patients with type 2 diabetes and artery disease. High-intensity interval exercise was found to suppress appetite and boost metabolic markers in people with overweight or obesity. Continuous glucose monitoring in primary care improved blood sugar control and cut hospitalizations for insulin-dependent patients. In a notable finding, endometriosis may be driven by androgen hormones rather than estrogen alone, based on steroid profiling data. Meanwhile, bariatric surgery showed lower long-term healthcare costs than GLP-1 drugs for patients with obesity and diabetes, raising important questions about treatment value.
